Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

African plants can treat hair issues and may help with diabetes.

Early detection and treatment of folliculitis keloidalis can prevent disease progression.

Hair analysis can help diagnose adrenal disorders non-invasively.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

K18® and Olaplex® both effectively repair bleached hair, improving its strength, smoothness, and overall health.

Women with type D personality and PCOS experience more stress and use less effective coping strategies.

Turning food waste into useful products is key for a sustainable economy.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

The herbal hair oil helped hair grow in mice.

Medicinal plants in Kurdistan have potential health benefits and need more research for drug development.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

A clinical nutrition program improved sensory and motor function in a 60-year-old with anti-MAG neuropathy.